Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Recommendation based on a phase 3 study showing a significantly ...

We want to build a healthier, more resilient world. We turn the impossible into the possible by discovering, developing, and delivering medicines and vaccines for millions of people around the world.

Please complete this form to contact Sanofi Canada. All information you provide will be maintained in accordance with our privacy policy. We provide product information and cannot offer medical advice ...

The phenomenon of smoldering-associated worsening in multiple sclerosis has been widely accepted by the medical community, yet much work is needed to fully integrate it into clinical practice.

Sanofi, RadioMedix, and Orano Med announce licensing agreement on next-generation radioligand medicine for rare cancers Paris, France, and Houston, Texas, ...

Dupixent phase 3 study confirms significant improvements in itch and hives for patients with CSU Confirming the results of CUPID-A, this second pivotal study in biologic-naïve patients ...

Sanofi inaugure la première usine modulable de vaccins et biomédicaments au monde à Neuville-sur-Saône Paris, le 10 septembre 2024. En présence du Président de la République, ...

ERS: Dupixent data reinforce clinically meaningful benefit from pooled analysis of two COPD phase 3 studies Pooled results from the BOREAS and NOTUS studies show meaningful clinical benefit ...

A Million Conversations is Sanofi’s global initiative to rebuild trust in healthcare with the underrepresented. Specifically with Black and ethnic minority groups, women, people with disabilities, and ...

At Sanofi, we’re proud to be premium partner of Paris 2024. Like Olympians and Paralympians, we spend every day challenging ourselves and each other to be better, go further, and to never, ever settle ...

We want to improve the lives of millions of people who don’t have access to the help they need. To do that, we’re expanding our health-system partnerships at local, regional, and global levels. We’re ...

The Translational Science Hub connects world-class researchers in Queensland with Sanofi scientists in France and the US, creating a first-of-its-kind, global scientific community focused on mRNA ...